학술논문
1042O - Durvalumab for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Preliminary results from a single-arm, phase 2 study
Document Type
Abstract
Author
Source
In Annals of Oncology September 2017 28 Supplement 5:v372-v372
Subject
Language
ISSN
0923-7534